Gilead Sciences
Gilead Sciences is a biopharmaceutical company that develops and commercialises therapeutics products. Gilead's Irish operations are responsible for manufacturing, quality control, packaging, and the release and distribution of the company's products in the EU and other international locations.
Financial Data
-
31st Dec 20 Source: CRO
- €4.6 billion turnover
-
-€1.5 billion
profit - 430 employees
-
31st Dec 19 Source: CRO
- €5.9 billion turnover
-
€257.5 million
profit - 406 employees
- 11 more years available »
Ranking
By Turnover
(€4.6 billion)- 26th in Top Companies
- 5th in Health
- 3rd in Pharma
By Employees
(430)- 400th in Top Companies
- 61st in Health
- 33rd in Pharma
-
- 430
- €4.6 billion
Employees
- David Cadogan Vice President}
Latest News
- 5:55am Consumer giant Procter & Gamble sells last Irish manufacturing plant
- 2:02am Nama clashes with Fingal council over lands with space for up to 7,000 new homes
- May 20 Attempt by investors to appoint inspector to firm ‘without precedent’, court hears
- May 20 Amarenco and SSE among groups to win green Eirgrid contracts
- May 20 Cerberus collected €113m last year from Irish loans it bought after the 2008 crash